- Home
- CGON vs HE Comparison
CGON vs HE Comparison
Compare CGON & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- HE
- Stock Information
- Founded
- CGON 2010
- HE 1891
- Country
- CGON United States
- HE United States
- Employees
- CGON N/A
- HE N/A
- Industry
- CGON
- HE Electric Utilities: Central
- Sector
- CGON
- HE Utilities
- Exchange
- CGON NYSE
- HE Nasdaq
- Market Cap
- CGON 2.1B
- HE 1.9B
- IPO Year
- CGON 2024
- HE N/A
- Fundamental
- Price
- CGON $25.55
- HE $10.38
- Analyst Decision
- CGON Strong Buy
- HE Hold
- Analyst Count
- CGON 10
- HE 4
- Target Price
- CGON $64.44
- HE $11.19
- AVG Volume (30 Days)
- CGON 784.3K
- HE 1.5M
- Earning Date
- CGON 08-07-2025
- HE 08-08-2025
- Dividend Yield
- CGON N/A
- HE N/A
- EPS Growth
- CGON N/A
- HE N/A
- EPS
- CGON N/A
- HE N/A
- Revenue
- CGON $662,000.00
- HE $3,171,906,000.00
- Revenue This Year
- CGON N/A
- HE $23.08
- Revenue Next Year
- CGON $14,719.70
- HE $1.74
- P/E Ratio
- CGON N/A
- HE N/A
- Revenue Growth
- CGON 224.51
- HE 0.66
- 52 Week Low
- CGON $14.80
- HE $7.61
- 52 Week High
- CGON $40.47
- HE $18.19
- Technical
- Relative Strength Index (RSI)
- CGON 48.31
- HE 46.52
- Support Level
- CGON $25.02
- HE $10.20
- Resistance Level
- CGON $26.97
- HE $10.81
- Average True Range (ATR)
- CGON 1.14
- HE 0.23
- MACD
- CGON -0.18
- HE -0.04
- Stochastic Oscillator
- CGON 17.79
- HE 34.85
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.